Nicotine pharmacokinetics of electronic cigarettes: A review of the literature

Regulatory Toxicology and Pharmacology

Volumn 100, Issue , 2018, Pages 25-34

  Fearon, Ian M ^a   Eldridge, Alison C ^b   Gale, Nathan ^b   McEwan, Mike ^b   Stiles, Mitchell F ^c   Round, Elaine K ^c  

^a CELERION   (United States)

^b BRITISH AMERICAN TOBACCO   (United Kingdom)

^c RAI Services Company   (United States)

Author keywords

Clinical studies; E cigarette; Human; Nicotine; Pharmacokinetics

Indexed keywords

NICOTINE; NICOTINIC AGENT;

BLOOD LEVEL; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; HUMAN; MAXIMUM CONCENTRATION; PHARMACOKINETIC ASSAY; PHARMACOKINETIC PARAMETERS; PRIORITY JOURNAL; REVIEW; ELECTRONIC CIGARETTE; METHODOLOGY;

ELECTRONIC NICOTINE DELIVERY SYSTEMS; HUMANS; NICOTINE; NICOTINIC AGONISTS; RESEARCH DESIGN;

EID: 85054802108     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2018.09.004     Document Type: Review

References (89)

1. Abdallah, I.A., Hammell, D.C., Stinchcomb, A.L., Hassan, H.E., A fully validated LC-MS/MS method for simultaneous determination of nicotine and its metabolite cotinine in human serum and its application to a pharmacokinetic study after using nicotine transdermal delivery systems with standard heat application in adult smokers. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 1020 (2016), 67–77.
2. Armitage, A., Dollery, C., Houseman, T., Kohner, E., Lewis, P.J., Turner, D., Absorption of nicotine from small cigars. Clin. Pharmacol. Ther. 23 (1978), 143–151.
3. Armitage, A.K., Turner, D.M., Absorption of nicotine in cigarette and cigar smoke through the oral mucosa. Nature 226 (1970), 1231–1232.
4. Azzopardi, D., Patel, K., Jaunky, T., Santopietro, S., Camacho, O.M., McAughey, J., Gaça, M., Electronic cigarette aerosol induces significantly less cytotoxicity than tobacco smoke. Toxicol. Mech. Meth. 26 (2016), 477–491.
5. Baker, R.R., Massey, E.D., Smith, G., An overview of the effects of tobacco ingredients on smoke chemistry and toxicity. Food Chem. Toxicol. 42 (2004), S53–S83.
6. Bannon, Y.B., Corish, J., Corrigan, O.I., Devane, J.G., Kavanagh, M., Mulligan, S., Transdermal delivery of nicotine in normal human volunteers: a single dose and multiple dose study. Eur. J. Clin. Pharmacol. 37 (1989), 285–290.
7. Benowitz, N.L., Porchet, H., Sheiner, L., Jacob, P. 3rd, Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum. Clin. Pharmacol. Ther. 44 (1988), 23–28.
8. nd 2015. https://patentimages.storage.googleapis.com/e2/9a/99/5a55ed883b0523/US9215895.pdf. Accessed on June 28th 2018.
9. Brown, J., Beard, E., Kotz, D., Michie, S., West, R.l., Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study. Addiction 109 (2014), 1531–1540.
10. Bullen, C., McRobbie, H., Thornley, S., Glover, M., Lin, R., Laugesen, M., Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial. Tobac. Contr. 19 (2010), 98–103.
11. Caldwell, B.O., Crane, J., Combination nicotine metered dose inhaler and nicotine patch for smoking cessation: a randomized controlled trial. Nicotine Tob. Res. 18 (2016), 1944–1951.
12. Caldwell, B., Dickson, S., Burgess, C., Siebers, R., Mala, S., Parkes, A., Crane, J., A pilot study of nicotine delivery to smokers from a metered-dose inhaler. Nicotine Tob. Res. 11 (2009), 342–347.
13. Cancer Research UK, E-cigarettes safer than smoking says long-term study. http://www.cancerresearchuk.org/about-us/cancer-news/press-release/2017-02-06-e-cigarettes-safer-than-smoking-says-long-term-study, 2017. (Accessed 21 March 2017)
14. Choi, J.H., Dresler, C.M., Norton, M.R., Strahs, K.R., Pharmacokinetics of a nicotine polacrilex lozenge. Nicotine Tob. Res. 5 (2003), 635–644.
15. Cunningham, A., Slayford, S., Vas, C., Gee, J., Costigan, S., Prasad, K., Development, validation and application of a device to measure e-cigarette users' puffing topography. Sci. Rep., 6, 2016, 35071.
16. Dawkins, L., Corcoran, O., Acute electronic cigarette use: nicotine delivery and subjective effects in regular users. Psychopharmacol. 231 (2014), 401–407.
17. Dawkins, L.E., Kimber, C.F., Doig, M., Feyerabend, C., Corcoran, O., Self-titration by experienced e-cigarette users: blood nicotine delivery and subjective effects. Psychopharmacol. 233 (2016), 2933–2941.
18. de Mendizábal, N.V., Jones, D.R., Jahn, A., Bies, R.R., Brown, J.W., Nicotine and cotinine exposure from electronic cigarettes: a population approach. Clin. Pharmacokinet. 54 (2015), 615–626.
19. Dempsey, D., Tutka, P., Jacob, P. 3rd, Allen, F., Schoedel, K., Tyndale, R.F., Benowitz, N.L., Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity. Clin. Pharmacol. Ther. 76 (2004), 64–72.
20. Digard, H., Proctor, C., Kulasekaran, A., Malmqvist, U., Richter, A., Determination of nicotine absorption from multiple tobacco products and nicotine gum. Nicotine Tob. Res. 15 (2013), 255–261.
21. D'Ruiz, C.D., Graff, D.W., Yan, X.S., Nicotine delivery, tolerability and reduction of smoking urge in smokers following short-term use of one brand of electronic cigarettes. BMC Publ. Health, 15, 2015, 991.
22. Duell, A.K., Pankow, J.F., Peyton, D.H., Free-base nicotine determination in electronic cigarette liquids by 1H NMR spectroscopy. Chem. Res. Toxicol. 31 (2018), 431–434.
23. El-Hellani, A., Salman, R., El-Hage, R., Talih, S., Malek, N., Baalbaki, R., Karaoghlanian, N., Nakkash, R., Shihadeh, A., Saliba, N.A., Nicotine and carbonyl emissions from popular electronic cigarette products: correlation to liquid composition and design characteristics. Nicotine Tob. Res. 20 (2018), 215–223.
24. Evans, S.E., Hoffman, A.C., Electronic cigarettes: abuse liability, topography and subjective effects. Tobac. Contr. 23 (2014), ii23–i29.
25. Fagerström, K.O., Hughes, J.R., Rasmussen, T., Callas, P.W., Randomised trial investigating effect of a novel nicotine delivery device (Eclipse) and a nicotine oral inhaler on smoking behaviour, nicotine and carbon monoxide exposure, and motivation to quit. Tobac. Contr. 9 (2000), 327–333.
26. Fant, R.V., Henningfield, J.E., Nelson, R.A., Pickworth, W.B., Pharmacokinetics and pharmacodynamics of moist snuff in humans. Tobac. Contr. 8 (1999), 387–392.
27. Fant, R.V., Henningfield, J.E., Shiffman, S., Strahs, K.R., Reitberg, D.P., A pharmacokinetic crossover study to compare the absorption characteristics of three transdermal nicotine patches. Pharmacol. Biochem. Behav. 67 (2000), 479–482.
28. Farsalinos, K.E., Spyrou, A., Stefopoulos, C., Tsimopoulou, K., Kourkoveli, P., Tsiapras, D., Kyrzopoulos, S., Poulas, K., Voudris, V., Nicotine absorption from electronic cigarette use: comparison between experienced consumers (vapers) and naïve users (smokers). Sci. Rep., 5, 2015, 11269.
29. Farsalinos, K.E., Spyrou, A., Tsimopoulou, K., Stefopoulos, C., Romagna, G., Voudris, V., Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices. Sci. Rep., 4, 2014, 4133.
30. FDA, Guidance for Industry: Modified Risk Tobacco Product Applications. 2012 https://www.fda.gov/downloads/TobaccoProducts/Labeling/RulesRegulationsGuidance/UCM297751.pdf. (Accessed 24 March 2017)
31. FDA, Premarket Tobacco Product Applications for Electronic Nicotine Delivery Systems Guidance for Industry. 2016 https://www.fda.gov/downloads/TobaccoProducts/Labeling/RulesRegulationsGuidance/UCM499352.pdf. (Accessed 24 March 2017)
32. Fearon, I.M., Eldridge, A., Gale, N., Shepperd, C.J., McEwan, M., Camacho, O.M., Nides, M., McAdam, K., Proctor, C.J., E-cigarette nicotine delivery: data and learnings from pharmacokinetic studies. Am. J. Health Behav. 41 (2017), 16–32.
33. Foulds, J., Russell, M.A., Jarvis, M.J., Feyerabend, C., Nicotine absorption and dependence in unlicensed lozenges available over the counter. Addiction 93 (1998), 1427–1431.
34. Goniewicz, M.L., Knysak, J., Gawron, M., Kosmider, L., Sobczak, A., Kurek, J., Prokopowicz, A., Jablonska-Czapla, M., Rosik-Dulewska, C., Havel, C., Jacob, P. 3rd, Benowitz, N., Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tobac. Contr. 23 (2014), 133–139.
35. Hajek, P., Goniewicz, M.L., Phillips, A., Myers Smith, K., West, O., McRobbie, H., Nicotine intake from electronic cigarettes on initial use and after 4 weeks of regular use. Nicotine Tob. Res. 17 (2015), 175–179.
36. Hajek, P., Przulj, D., Phillips, A., Anderson, R., McRobbie, H., Nicotine delivery to users from cigarettes and from different types of e-cigarettes. Psychopharmacol. 234 (2017), 773–779.
37. Hansson, A., Rasmussen, T., Kraiczi, H., Single-Dose and multiple-dose pharmacokinetics of nicotine 6 mg gum. Nicotine Tob. Res. 19 (2017), 477–483.
38. Hasenfratz, M., Bättig, K., Nicotine absorption and the subjective and physiologic effects of nicotine toothpicks. Clin. Pharmacol. Ther. 50 (1991), 456–461.
39. Hartmann-Boyce, J., McRobbie, H., Bullen, C., Begh, R., Stead, L.F., Hajek, P., Electronic cigarettes for smoking cessation. Cochrane Database Syst. Rev., 9, 2016, CD010216.
40. Kalkhoran, S., Glantz, S.A., E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis. Lancet Respir. Med. 4 (2016), 116–128.
41. Koszowski, B., Rosenberry, Z.R., Kanu, A., Viray, L.C., Potts, J.L., Pickworth, W.B., Nicotine and carbon monoxide exposure from inhalation of cigarillo smoke. Pharmacol. Biochem. Behav. 139 (2015), 7–14.
42. Koszowski, B., Viray, L.C., Stanfill, S.B., Lisko, J.G., Rosenberry, Z.R., Potts, J.L., Pickworth, W.B., Nicotine delivery and pharmacologic response from Verve, an oral nicotine delivery product. Pharmacol. Biochem. Behav. 136 (2015), 1–6.
43. Kotlyar, M., Mendoza-Baumgart, M.I., Li, Z.Z., Pentel, P.R., Barnett, B.C., Feuer, R.M., Smith, E.A., Hatsukami, D.K., Nicotine pharmacokinetics and subjective effects of three potential reduced exposure products, moist snuff and nicotine lozenge. Tobac. Contr. 16 (2007), 138–142.
44. Kraiczi, H., Hansson, A., Perfekt, R., Single-dose pharmacokinetics of nicotine when given with a novel mouth spray for nicotine replacement therapy. Nicotine Tob. Res. 13 (2011), 1176–1182.
45. Lee, E.M., Malson, J.L., Moolchan, E.T., Pickworth, W.B., Quantitative comparisons between a nicotine delivery device (Eclipse) and conventional cigarette smoking. Nicotine Tob. Res. 6 (2004), 95–102.
46. Leischow, S.J., Sachs, D.P., Hansen, M.D., Bostrom, A.G., Nicotine polacrilex dose effects: serum nicotine levels and sensory characteristics. Psychopharmacol. 117 (1995), 125–129.
47. Lopez, A.A., Hiler, M.M., Soule, E.K., Ramôa, C.P., Karaoghlanian, N.V., Lipato, T., Breland, A.B., Shihadeh, A.L., Eissenberg, T., Effects of electronic cigarette liquid nicotine concentration on plasma nicotine and puff topography in tobacco cigarette smokers: a preliminary report. Nicotine Tob. Res. 18 (2016), 720–723.
48. Lunell, E., Curvall, M., Nicotine delivery and subjective effects of Swedish portion snus compared with 4 mg nicotine polacrilex chewing gum. Nicotine Tob. Res. 13 (2011), 573–578.
49. Lunell, E., Lunell, M., Steady-state nicotine plasma levels following use of four different types of Swedish snus compared with 2-mg Nicorette chewing gum: a crossover study. Nicotine Tob. Res. 7 (2005), 397–403.
50. McRobbie, H., Phillips, A., Goniewicz, M.L., Smith, K.M., Knight-West, O., Przulj, D., Hajek, P., Effects of switching to electronic cigarettes with and without concurrent smoking on exposure to nicotine, carbon monoxide, and acrolein. Canc. Prev. Res. 8 (2015), 873–878.
51. McRobbie, H., Thornley, S., Bullen, C., Lin, R.B., Senior, H., Laugesen, M., Whittaker, R., Hajek, P., A randomized trial of the effects of two novel nicotine replacement therapies on tobacco withdrawal symptoms and user satisfaction. Addiction 105 (2010), 1290–1298.
52. McKinney, D.L., Gogova, M., Davies, B.D., Ramakrishnan, V., Fisher, K., Carter, W.H., Karnes, H.T., Garnett, W.R., Iyer, S.S., Somani, A.A., Kobal, G., Barr, W.H., Evaluation of the effect of ammonia on nicotine pharmacokinetics using rapid arterial sampling. Nicotine Tob. Res. 14 (2012), 586–595.
53. McNeil, A., Brose, L.S., Calder, R., Hitchman, S.C., Hajek, P., McRobbie, H., E-cigarettes: an Evidence Update. A Report Commissioned by Public Health England., 2015 https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/457102/Ecigarettes_an_evidence_update_A_report_commissioned_by_Public_Health_England_FINAL.pdf. (Accessed 25 April 2016)
54. McNeil, A., Brose, L.S., Calder, R., Bauld, L., Robson, D., Evidence review of e-cigarettes and heated tobacco products 2018. A report commissioned by Public Health England., 2018 https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/684963/Evidence_review_of_e-cigarettes_and_heated_tobacco_products_2018.pdf. (Accessed 15 May 2018)
55. Miura, N., Yuki, D., Minami, N., Kakehi, A., Onozawa, M., Pharmacokinetic analysis of nicotine when using non-combustion inhaler type of tobacco product in Japanese adult male smokers. Regul. Toxicol. Pharmacol. 67 (2013), 198–205.
56. Moyer, T.P., Charlson, J.R., Enger, R.J., Dale, L.C., Ebbert, J.O., Schroeder, D.R., Hurt, R.D., Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profiles. Clin. Chem. 48 (2002), 1460–1471.
57. Moyses, C., Hearn, A., Redfern, A., Evaluation of a novel nicotine inhaler device: part 1–arterial and venous pharmacokinetics. Nicotine Tob. Res. 17 (2015), 18–25.
58. New Zealand Ministry of Health, E-cigarettes. http://www.health.govt.nz/our-work/preventative-health-wellness/tobacco-control/e-cigarettes, 2016. (Accessed 24 March 2017)
59. Nides, M.A., Leischow, S.J., Bhatter, M., Simmons, M., Nicotine blood levels and short-term smoking reduction with an electronic nicotine delivery system. Am. J. Health Behav. 38 (2014), 265–274.
60. Palazzolo, D.L., Electronic cigarettes and vaping: a new challenge in clinical medicine and public health. A literature review. Front. Pub. Health, 1, 2013, 56.
61. Pasquereau, A., Guignard, R., Andler, R., Nguyen-Thanh, V., Electronic cigarettes, quit attempts and smoking cessation: a 6-month follow-up. Addiction 112 (2017), 1620–1628.
62. Picavet, P., Haziza, C., Lama, N., Weitkunat, R., Lüdicke, F., Comparison of the pharmacokinetics of nicotine following single and ad libitum use of a tobacco heating system or combustible cigarettes. Nicotine Tob. Res. 18 (2016), 557–563.
63. Ramôa, C.,P., Hiler, M.M., Spindle, T.R., Lopez, A.A., Karaoghlanian, N., Lipato, T., Breland, A.B., Shihadeh, A., Eissenberg, T., Electronic cigarette nicotine delivery can exceed that of combustible cigarettes: a preliminary report. Tobac. Contr. 25 (2016), e6–9.
64. Rees, V.W., Kreslake, J.M., Wayne, G.F., O'Connor, R.J., Cummings, K.M., Connolly, G.N., Role of cigarette sensory cues in modifying puffing topography. Drug Alcohol Depend. 124 (2012), 1–10.
65. Rennard, S.I., Glover, E.D., Leischow, S., Daughton, D.M., Glover, P.N., Muramoto, M., Franzon, M., Danielsson, T., Landfeldt, B., Westin, A., Efficacy of the nicotine inhaler in smoking reduction: a double-blind, randomized trial. Nicotine Tob. Res. 8 (2006), 555–564.
66. R.J. Reynolds Tobacco Company, Chemical and Biological Studies on New Cigarette Prototypes that Heat Instead of Burn Tobacco. 1988, Winston-Salem, N.C: R.J. Reynolds Tobacco Co.
67. Rodgman, A., Perfetti, T.A., The Chemical Components of Tobacco and Tobacco Smoke. second ed., 2013, CRC Pres, Boca Raton.
68. Rose, J.E., Turner, J.E., Murugesan, T., Behm, F.M., Laugesen, M., Pulmonary delivery of nicotine pyruvate: sensory and pharmacokinetic characteristics. Exp. Clin. Psychopharmacol 18 (2010), 385–394.
69. Royal College of Physicians, Nicotine without Smoke: Tobacco Harm Reduction. 2016, Royal College of Physicians, London.
70. Russell, M.A., Low-tar medium-nicotine cigarettes: a new approach to safer smoking. Br. Med. J. 1 (1976), 1430–1433.
71. Russell, M.A., Feyerabend, C., Cole, P.V., Plasma nicotine levels after cigarette smoking and chewing nicotine gum. Br. Med. J. 1 (1976), 1043–1046.
72. Shihadeh, A., Eissenberg, T., Electronic cigarette effectiveness and abuse liability: predicting and regulating nicotine flux. Nicotine Tob. Res. 17 (2015), 158–162.
73. Stapleton, J.A., Russell, M.A., Sutherland, G., Feyerabend, C., Nicotine availability from Eclipse tobacco-heating cigarette. Psychopharmacol. 139 (1998), 288–290.
74. Steinberg, M.B., Zimmermann, M.H., Delnevo, C.D., Lewis, M.J., Shukla, P., Coups, E.J., Foulds, J., E-cigarette versus nicotine inhaler: comparing the perceptions and experiences of inhaled nicotine devices. J. Gen. Intern. Med. 29 (2014), 1444–1450.
75. St Helen, G., Havel, C., Dempsey, D.A., Jacob, P. 3rd, Benowitz, N.L., Nicotine delivery, retention and pharmacokinetics from various electronic cigarettes. Addiction 111 (2016), 535–544.
76. St Helen, G., Dempsey, D.A., Havel, C.M., Jacob, P. 3rd, Benowitz, N.L., Impact of e-liquid flavors on nicotine intake and pharmacology of e-cigarettes. Drug Alcohol Depend. 178 (2017), 391–398.
77. Stiles, M.F., Campbell, L.R., Graff, D.W., Jones, B.A., Fant, R.V., Henningfield, J.E., Pharmacodynamic and pharmacokinetic assessment of electronic cigarettes, combustible cigarettes, and nicotine gum: implications for abuse liability. Psychopharmacol. 234 (2017), 2643–2655.
78. Stiles, M.F., Campbell, L.R., Jin, T., Graff, D.W., Fant, R.V., Henningfield, J.E., Assessment of the abuse liability of three menthol Vuse Solo electronic cigarettes relative to combustible cigarettes and nicotine gum. Psychopharmacol. 235 (2018), 2077–2086.
79. Talih, S., Balhas, Z., Eissenberg, T., Salman, R., Karaoghlanian, N., El Hellani, A., Baalbaki, R., Saliba, N., Shihadeh, A., Effects of user puff topography, device voltage, and liquid nicotine concentration on electronic cigarette nicotine yield: measurements and model predictions. Nicotine Tob. Res. 17 (2015), 150–157.
80. Talih, S., Balhas, Z., Salman, R., El-Hage, R., Karaoghlanian, N., El-Hellani, A., Baassiri, M., Jaroudi, E., Eissenberg, T., Saliba, N., Shihadeh, A., Transport phenomena governing nicotine emissions from electronic cigarettes: model formulation and experimental investigation. Aerosol Sci. Technol. 51 (2017), 1–11.
81. Taylor, M., Carr, T., Oke, O., Jaunky, T., Breheny, D., Lowe, F., Gaça, M., E-cigarette aerosols induce lower oxidative stress in vitro when compared to tobacco smoke Toxicol. Mech. Meth. 26 (2016), 465–476.
82. Teeguarden, J.G., Housand, C.J., Smith, J.N., Hinderliter, P.M., Gunawan, R., Timchalk, C.A., A multi-route model of nicotine-cotinine pharmacokinetics, pharmacodynamics and brain nicotinic acetylcholine receptor binding in humans. Regul. Toxicol. Pharmacol. 65 (2013), 12–28.
83. Vansickel, A.R., Cobb, C.O., Weaver, M.F., Eissenberg, T.E., A clinical laboratory model for evaluating the acute effects of electronic “cigarettes”: nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol. Biomark. Prev. 19 (2010), 1945–1953.
84. Vansickel, A.R., Eissenberg, T., Electronic cigarettes: effective nicotine delivery after acute administration. Nicotine Tob. Res. 15 (2013), 267–270.
85. Walele, T., Sharma, G., Savioz, R., Martin, C., Williams, J., A randomised, crossover study on an electronic vapour product, a nicotine inhalator and a conventional cigarette. Part A: Pharmacokinetics. Regul. Toxicol. Pharmacol. 74 (2016), 187–192.
86. Wagener, T.L., Floyd, E.L., Stepanov, I., Driskill, L.M., Frank, S.G., Meier, E., Leavens, E.L., Tackett, A.P., Molina, N., Queimado, L., Have combustible cigarettes met their match? The nicotine delivery profiles and harmful constituent exposures of second-generation and third-generation electronic cigarette users. Tobac. Contr. 26 (2017), e23–e28.
87. Yan, X.S., D'Ruiz, C., Effects of using electronic cigarettes on nicotine delivery and cardiovascular function in comparison with regular cigarettes. Regul. Toxicol. Pharmacol. 71 (2015), 24–34.
88. Yun, H.Y., Seo, J.W., Choi, J.E., Baek, I.H., Kang, W., Kwon, K.I., Effects of smoking on the pharmacokinetics and pharmacodynamics of a nicotine patch. Biopharm Drug Dispos. 29 (2008), 521–528.
89. Zhu, S.H., Zhuang, Y.L., Wong, S., Cummins, S.E., Tedeschi, G.J., E-cigarette use and associated changes in population smoking cessation: evidence from US current population surveys. Br. Med. J., 358, 2017, j3262.